(Press-News.org) MIAMA BEACH, FL (October 4, 2011)––In a new study led by Fox Chase Cancer Center radiation oncologist Natasha Townsend, M.D., researchers have found that Gleason scores determined by pathologists at Fox Chase Cancer Center more accurately predict the risk of recurrence than Gleason scores from referring institutions. She presented the new research at the 53rd Annual Meeting of the American Society for Radiation Oncology on Monday, October 3.
When a man is diagnosed with prostate cancer, his tumor is assigned a Gleason score – a number between 2 and 10 indicating the aggressiveness of the cancer and likelihood that the cancer will spread to other parts of his body. In general, Gleason scores 2 to 6 are considered low, 7 is intermediate, and 8 to 10 are high. A patients Gleason score is used to make important treatment decisions.
Townsend and her team looked at the records of 1,649 men who had undergone radiation therapy at Fox Chase between 1994 and 2007. Fox Chase pathologists reviewed the cases of every patient referred to the Center from another institution and determined the Gleason score, so Townsend compared those scores to scores from pathologists at the referring institutions (e.g. urologists, private pathologists' offices, and other centers that specialize in prostate cancer treatment).
A minor increase or decrease in Gleason score can significantly alter a patient's treatment, says Townsend. "We learned that twenty percent, or one in five men, with a Gleason score 7 by the referring institution were determined to have a Gleason score 2 to 6 at Fox Chase," Townsend added. "This is important because not only is the prognosis much better but, it changes what treatment might be recommended. For example, patients with Gleason 6 disease are more likely to be offered brachytherapy (i.e. prostate radioactive seeding) and uncommonly treated with androgen deprivation therapy, which strongly impacts quality of life."
Even greater benefits were seen in patients determined to have Gleason score 8 to10 disease by the referring institution. "An alarming 58% of patients with Gleason score 8 to 10 disease in our study were unconfirmed. These patients were found to have lower Gleason scores and similarly better prognosis," says Townsend. Patients with Gleason score 8 to 10 are universally characterized as having "high-risk" disease and a common practice standard is treatment with combination external beam radiotherapy and hormone therapy. When the Gleason score is lower, physicians are more confident omitting hormone therapy and avoiding the side effects that go along with that treatment.
Pathologists who specialize in prostate cancer likely explain the difference between the Gleason scores. "Most cases were examined by an oncologic pathologist with a special experience in urologic pathology," says Tahseen Al-Seleem, M.D., Fox Chase pathologist and co-author on the study. "Cases with discrepancy in diagnosis or grading with the outside institutions were examined by a panel of at least two oncologic pathologists until a consensus diagnosis was reached."
Changing the Gleason score is meaningless however, unless the changes better predict how patients will do following treatment. "Historically, we know Gleason score 6 patients fare better than Gleason 7, who fare better than Gleason 8 to10. Our study shows that the Fox Chase Gleason scores better predicted this pattern than the referring institutions. This reassures us that the changes made by Fox Chase pathologists were more accurate, enabling our doctors to better advise patients about treatment options and outcomes," says Mark K. Buyyounouski, M.D., M.S., Fox Chase radiation oncologist and senior author on the study. "Quality treatment for prostate cancer begins with understanding how aggressive the cancer may be and how far along it may have progressed. This study is an example of how a second opinion about the biopsy results improves quality."
###
Co-investigators include Karen Ruth, Tahseen Al-Saleem, Eric Horwitz, Mark Sobczak, Robert Uzzo, Rosalia Viterbo, and Mark Buyyounouski from Fox Chase.
Fox Chase Cancer Center is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation's first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center's nursing program has received the Magnet status for excellence three consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, visit Fox Chase's Web site at www.foxchase.org or call 1-888-FOX CHASE or (1-888-369-2427).
END
DENVER (Oct. 5, 2011) – A new study shows that using the Internet to look for a job reduces the time spent unemployed by an average of 25 percent.
The discovery directly contradicts a 2004 study showing that using the Internet actually prolonged unemployment.
"In 2004 the researchers came up with two scenarios for their findings – the Internet was not an effective tool or that people who looked on-line for jobs were not as qualified," said Hani Mansour, Ph.D., assistant professor of economics at the University of Colorado Denver who conducted the new study with Peter ...
More than 100 artefacts from the First World War have been uncovered in an archaeological fieldwork survey on the Gallipoli battlefield, leading to some interesting theories about life on the frontline according to University of Melbourne survey archaeologist Professor Antonio Sagona.
The discoveries were made as part of a second season of fieldwork undertaken as part of the Joint Historical and Archaeological Survey – the only systematic survey of the battlefields of Gallipoli since the First World War.
The survey covered the northern frontline areas on the Turkish ...
A new insight into global photosynthesis, the chemical process governing how ocean and land plants absorb and release carbon dioxide, has been revealed in research that will assist scientists to more accurately assess future climate change.
In a paper published today in Nature, a team of US, Dutch and Australian scientists have estimated that the global rate of photosynthesis, the chemical process governing the way ocean and land plants absorb and release CO2, occurs 25% faster than previously thought.
From analysing more than 30 years of data collected by Scripps Institution ...
Interactive video games, already known to improve motor function in
recovering stroke patients, appear to safely enhance physical therapy
for patients in intensive care units (ICU), new research from Johns
Hopkins suggests.
In a report published online in the Journal of Critical Care,
researchers studied the safety and feasibility of using video games to
complement regular physical therapy in the ICU.
"Patients admitted to our medical intensive care unit are very sick and,
despite early physical therapy, still experience problems with muscle
weakness, balance ...
"Too busy," and "too complicated." These are the typical excuses one might expect when medical professionals are asked why they fail to use online error-reporting systems designed to improve patient safety and the quality of care. But, Johns Hopkins investigators found instead that the most common reason among radiation oncologists was fear of getting into trouble and embarrassment.
Investigators e-mailed an anonymous survey to physicians, nurses, radiation physicists and other radiation specialists at Johns Hopkins, North Shore- Long Island Jewish Health System in New ...
A team of scientists, led by Johns Hopkins researchers, say they may have found a way to predict how quickly patients with Alzheimer's disease (AD) will lose cognitive function by looking at ratios of two fatty compounds in their blood. The finding, they say, could provide useful information to families and caregivers, and might also suggest treatment targets for this heartbreaking and incurable neurodegenerative disorder.
Past research has shown that cognitive function declines at different rates in AD patients, with roughly one-third not declining at all in five years, ...
A new study from the University of Adelaide shows the parents of women with polycystic ovary syndrome (PCOS) are more likely to have some form of cardiovascular disease.
PCOS is a hormonal disorder affecting about 10% of women of reproductive age. It is one of the most common endocrine disorders in women and a leading cause of infertility.
The study shows mothers of women with PCOS are more likely to have any form of cardiovascular disease, and almost twice as likely to have high blood pressure, than mothers of other women.
Fathers of women with PCOS are more than ...
ST. PAUL, Minn. – People who rate their health as poor or fair appear to be significantly more likely to develop dementia later in life, according to a study published in the October 5, 2011, online issue of Neurology®, the medical journal of the American Academy of Neurology.
"Having people rate their own health may be a simple tool for doctors to determine a person's risk of dementia, especially for people with no symptoms or memory problems," said study author Christophe Tzourio, MD, PhD, director of the Inserm unit 708 Neuroepidemiology at the University of Bordeaux ...
STANFORD, Calif. -- North American babies who acquire toxoplasmosis infections in the womb show much higher rates of brain and eye damage than European infants with the same infection, according to new research from the Stanford University School of Medicine.
Eighty-four percent of the North American infants studied had serious complications of the parasitic infection, including calcium deposits in the brain, water on the brain and eye disease that caused visual impairment or blindness. By contrast, few European infants had these problems -- for instance, about 17 percent ...
CHAMPAIGN, Ill. — Scientists call it LUCA, the Last Universal Common Ancestor, but they don't know much about this great-grandparent of all living things. Many believe LUCA was little more than a crude assemblage of molecular parts, a chemical soup out of which evolution gradually constructed more complex forms. Some scientists still debate whether it was even a cell.
New evidence suggests that LUCA was a sophisticated organism after all, with a complex structure recognizable as a cell, researchers report. Their study appears in the journal Biology Direct.
The study ...
